Company intelligence / Profile preview

Veganic Bio

Ashdod, Israel

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Veganic is a biotechnology company specializing in molecular farming to produce high-quality, animal-free recombinant proteins. The company utilizes a proprietary plant-based expression platform to manufacture human-identical proteins, with a primary focus on recombinant human collagen. Their technology aims to provide a sustainable, scalable, and pathogen-free alternative to animal-derived proteins for applications in medical aesthetics, tissue engineering, and wound care. By leveraging plants as bioreactors, Veganic seeks to disrupt the traditional protein production market with cost-effective and ethical solutions.

Therapeutic areas: OtherDermatology
Modalities: Recombinant protein
Industry: Biotech

Beyond the preview

Go deeper on Veganic Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Veganic Bio.

Explore the full profile